Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseases.
about
Shouts, whispers and the kiss of death: directional secretion in T cellsThe flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system.Tumor necrosis factor-alpha stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neuronsPoxvirus-encoded gamma interferon binding protein dampens the host immune response to infectionInfliximab for chronic obstructive pulmonary disease: towards a more specific inflammation targeting?Astrocytes--friends or foes in multiple sclerosis?Hairpin ribozyme-antisense RNA constructs can act as molecular Lassos.Adalimumab in the treatment of immune-mediated diseases.Somatostatin receptor scintigraphy in patients with rheumatoid arthritis and secondary Sjögren's syndrome treated with Infliximab: a pilot study.TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis.T cells use two directionally distinct pathways for cytokine secretion.Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2.Effects of propyl gallate on interaction between TNF-alpha and sTNFR-I using an affinity biosensor.Association of Tumor Necrosis Factor-α (TNF-α) Gene Promoter Polymorphisms with Aggressive and Chronic Periodontitis in Eastern Indian population.Tumor necrosis factor-Alpha stimulates cytokine expression and transient sensitization of trigeminal nociceptive neurons.Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: Calprotectin and IL-6 changes do not correspond to sRAGE changes
P2860
Q34001889-797E4BEA-66B5-4010-84ED-3AFB794B6E54Q34429376-1BECB62E-A9A5-4FE5-8B6D-95B56EDF0A23Q34708824-4A256123-32C2-4268-8543-C46CC7DCBC4AQ35784998-E8CF7812-BD8F-41E6-85C2-BD04E15D6BD1Q36376453-CCC8BF57-7256-494A-AEF5-252B7D2600DEQ36878427-43931D77-A213-400C-BACD-FBF6CDD9325EQ36986720-8C2D8465-7166-46DA-89F7-9ADFEB30631AQ38207760-716E2FF7-579E-4A18-9482-D5FC4DEB76E2Q42741713-2F159697-647A-473A-A9DB-A1BD510E0D1BQ44452432-3DB45AA7-5BC7-4FB9-A93D-C2344D2C8EFEQ45948164-63C63303-AB3B-4DA1-84D1-41B21164ADB4Q46685848-172A263A-AB8D-46DC-9679-ED0A2B6CAB7FQ46713144-75FD5899-1F79-4CB7-843C-79FBFB559B97Q49960579-9272536D-F07F-48BC-BD3E-9EDC0615EB6AQ50123118-F3DB42E4-1E3B-402F-A41C-1F696496F269Q57825203-8E3A16F7-EFCB-42C8-A995-6982541EB16C
P2860
Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseases.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Tumour necrosis factor alpha a ...... ediated inflammatory diseases.
@ast
Tumour necrosis factor alpha a ...... ediated inflammatory diseases.
@en
type
label
Tumour necrosis factor alpha a ...... ediated inflammatory diseases.
@ast
Tumour necrosis factor alpha a ...... ediated inflammatory diseases.
@en
prefLabel
Tumour necrosis factor alpha a ...... ediated inflammatory diseases.
@ast
Tumour necrosis factor alpha a ...... ediated inflammatory diseases.
@en
P2093
P1476
Tumour necrosis factor alpha a ...... ediated inflammatory diseases.
@en
P2093
Marc Feldmann
Peter C Taylor
Richard O Williams
P304
P356
10.1016/J.COPBIO.2004.09.005
P577
2004-12-01T00:00:00Z